Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-26 Sale |
2023-09-28 5:30 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
6,000,000 | $0.5 | $3,000,000 | 17,652,466 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-24 Tax Withholding |
2024-02-27 5:11 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
40,272 | $1.13 | 2,552,204 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:42 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH |
150,000 | $0 | 200,982 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:42 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
712,500 | $0 | 844,262 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:41 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
712,500 | $0 | 843,505 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:40 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
712,500 | $0 | 856,672 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 4:39 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
2,000,000 | $0 | 2,592,476 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:20 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
1,329 | $0.3821 | 126,762 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:19 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $0.3821 | 212,471 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:19 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
10,411 | $0.3821 | 592,476 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:18 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
1,030 | $0.3821 | 136,270 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:17 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
1,329 | $0.3821 | 131,005 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:16 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $0.3821 | 139,172 (Direct) |
View |
| 2023-11-25 Tax Withholding |
2023-11-28 4:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, Head of Research |
490 | $0.3821 | 50,982 (Direct) |
View |
Ownership |
2023-11-28 4:14 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, Head of Research |
0 | $0 | 199,805 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
1,029 | $0.77 | 137,300 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:15 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $0.77 | 214,396 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:14 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
1,329 | $0.77 | 132,334 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
10,411 | $0.77 | 602,887 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:13 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $0.77 | 140,634 (Direct) |
View |
| 2023-08-25 Tax Withholding |
2023-08-29 4:12 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
1,329 | $0.77 | 128,091 (Direct) |
View |
| 2023-08-13 Tax Withholding |
2023-08-15 4:55 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
864 | $1.08 | 129,420 (Direct) |
View |
| 2023-06-25 Tax Withholding |
2023-06-26 4:31 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
11,528 | $1.19 | 211,321 (Direct) |
View |
| 2023-06-11 Tax Withholding |
2023-06-13 4:55 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
864 | $1.19 | 133,663 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:52 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director |
41,650 | $0 | 79,850 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:51 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director |
41,650 | $0 | 90,350 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:50 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director |
41,650 | $0 | 77,350 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:49 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Markels John Director |
41,650 | $0 | 74,134 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:48 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director |
41,650 | $0 | 60,400 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:48 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director |
41,650 | $0 | 77,350 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:47 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director |
41,650 | $0 | 77,350 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 4:46 pm |
N/A 2033-05-31 |
SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director |
41,650 | $0 | 60,400 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:45 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
1,328 | $1.33 | 125,284 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:44 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations |
1,750 | $1.33 | 171,467 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:43 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer |
1,925 | $1.33 | 222,849 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:43 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer |
1,462 | $1.33 | 137,096 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:42 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer |
1,029 | $1.33 | 138,329 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:41 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer |
1,328 | $1.33 | 132,052 (Direct) |
View |
| 2023-05-25 Tax Withholding |
2023-05-30 4:40 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director |
10,411 | $1.33 | 613,298 (Direct) |
View |
| 2023-04-24 Tax Withholding |
2023-04-26 5:22 pm |
N/A N/A |
SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary |
3,977 | $1.65 | 126,612 (Direct) |
View |